Northern Trust’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.62M | Buy |
292,117
+198,809
| +213% | +$1.08M | ﹤0.01% | 3251 |
|
|
2026
Q1 | $562K | Buy |
+93,308
| New | +$535K | ﹤0.01% | 3575 |
|
|
2025
Q1 | – | Sell |
-36,878
| Closed | -$81.9K | – | 4482 |
|
|
2024
Q4 | $81.9K | Buy |
36,878
+13,829
| +60% | +$32.6K | ﹤0.01% | 4195 |
|
|
2024
Q3 | $61.5K | Hold |
23,049
| – | – | ﹤0.01% | 4167 |
|
|
2024
Q2 | $73.5K | Sell |
23,049
-37
| -0.2% | -$100 | ﹤0.01% | 4122 |
|
|
2024
Q1 | $59.6K | Sell |
23,086
-1,900
| -8% | -$11.7K | ﹤0.01% | 4196 |
|
|
2023
Q4 | $154K | Buy |
+24,986
| New | +$143K | ﹤0.01% | 3993 |
|
|
2022
Q2 | – | Sell |
-8,194
| Closed | -$54K | – | 4793 |
|
|
2022
Q1 | $54K | Sell |
8,194
-318
| -4% | -$1.95K | ﹤0.01% | 4517 |
|
|
2021
Q4 | $54K | Hold |
8,512
| – | – | ﹤0.01% | 4583 |
|
|
2021
Q3 | $119K | Hold |
8,512
| – | – | ﹤0.01% | 4359 |
|
|
2021
Q2 | $158K | Sell |
8,512
-37,521
| -82% | -$808K | ﹤0.01% | 4236 |
|
|
2021
Q1 | $1.08M | Sell |
46,033
-2,776
| -6% | -$69.4K | ﹤0.01% | 3567 |
|
|
2020
Q4 | $914K | Buy |
48,809
+1,320
| +3% | +$33.2K | ﹤0.01% | 3544 |
|
|
2020
Q3 | $1.21M | Buy |
47,489
+5,628
| +13% | +$152K | ﹤0.01% | 3311 |
|
|
2020
Q2 | $1.21M | Sell |
41,861
-4,913
| -11% | -$288K | ﹤0.01% | 3288 |
|
|
2020
Q1 | $2.25M | Buy |
46,774
+1,185
| +3% | +$71.5K | ﹤0.01% | 2786 |
|
|
2019
Q4 | $2.59M | Sell |
45,589
-5,307
| -10% | -$234K | ﹤0.01% | 2965 |
|
|
2019
Q3 | $3.15M | Buy |
50,896
+863
| +2% | +$48.9K | ﹤0.01% | 2825 |
|
|
2019
Q2 | $2.25M | Buy |
50,033
+2,796
| +6% | +$140K | ﹤0.01% | 3024 |
|
|
2019
Q1 | $2.97M | Buy |
47,237
+1,905
| +4% | +$114K | ﹤0.01% | 2847 |
|
|
2018
Q4 | $2.44M | Sell |
45,332
-1,773
| -4% | -$130K | ﹤0.01% | 2941 |
|
|
2018
Q3 | $4.73M | Buy |
47,105
+2,255
| +5% | +$169K | ﹤0.01% | 2711 |
|
|
2018
Q2 | $2.96M | Buy |
44,850
+7,074
| +19% | +$430K | ﹤0.01% | 2989 |
|
|
2018
Q1 | $1.89M | Sell |
37,776
-3,372
| -8% | -$162K | ﹤0.01% | 3132 |
|
|
2017
Q4 | $1.99M | Sell |
41,148
-3,728
| -8% | -$185K | ﹤0.01% | 3140 |
|
|
2017
Q3 | $2.73M | Buy |
44,876
+7,563
| +20% | +$434K | ﹤0.01% | 2997 |
|
|
2017
Q2 | $2.64M | Buy |
37,313
+8,132
| +28% | +$526K | ﹤0.01% | 2998 |
|
|
2017
Q1 | $1.89M | Sell |
29,181
-472
| -2% | -$36.7K | ﹤0.01% | 3107 |
|
|
2016
Q4 | $2.79M | Buy |
29,653
+2,583
| +10% | +$264K | ﹤0.01% | 2905 |
|
|
2016
Q3 | $3.06M | Buy |
27,070
+4,756
| +21% | +$461K | ﹤0.01% | 2833 |
|
|
2016
Q2 | $1.82M | Buy |
+22,314
| New | +$1.42M | ﹤0.01% | 3092 |
|
Other funds holding NERV
JT
VC
LGM
FCM
ABG
FCMV
Northern Trust's NERV Position: Q2 2026 in Review
Northern Trust increased its Minerva Neurosciences (NERV) stake by 213% in Q2 2026, buying an estimated $1.08M and bringing the position to 292,117 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3251.
Northern Trust first reported a position in NERV in Q2 2016 and has held it in 31 quarters since. The position peaked at $4.73M in Q3 2018. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.
- Northern Trust held 292,117 shares of Minerva Neurosciences worth $1.62M as of Q2 2026.
- Northern Trust bought 198,809 Minerva Neurosciences shares in Q2 2026, an estimated $1.08M.
- Minerva Neurosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3251 holding.
- Northern Trust first reported a position in Minerva Neurosciences in Q2 2016 and has held it in 31 quarters since.
- Northern Trust's Minerva Neurosciences position peaked at $4.73M in Q3 2018.
- 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.